申请人:Ensinger Carol L.
公开号:US20090221821A1
公开(公告)日:2009-09-03
The invention is based on the discovery that compounds of Formula I are unexpectedly highly potent and selective inhibitors of the adenosine A
1
receptor. Adenosine A
1
antagonists can be useful in the prevention and/or treatment of numerous diseases, including cardiac and circulatory disorders, degenerative disorders of the central nervous system, respiratory disorders, and many diseases for which diuretic treatment is suitable.
In one embodiment, the invention features a compound of formula I:
该发明基于发现,公式I化合物是意外地高效和选择性地抑制腺苷A1受体的抑制剂。腺苷A1拮抗剂可用于预防和/或治疗许多疾病,包括心脏和循环系统疾病,中枢神经系统退行性疾病,呼吸系统疾病以及许多适合利尿治疗的疾病。在一种实施例中,该发明涉及公式I的化合物: